Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Translational and Neurocomputational Evaluation of a Dopamine Receptor 1 Partial Agonist for Schizophrenia

NCT04457310 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT04457310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04457310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Translational and Neurocomputational Evaluation of a Dopamine Receptor 1 Partial Agonist for Schizophrenia
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Completed
Start date
March 2, 2021
Completion date
March 22, 2024
Enrollment
112 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

early course schizophrenia spectrum disorder